Probiotics for Psoriasis: What the Clinical Trials Show
Share
Unlike several natural interventions we've reviewed with disappointing meta-analytic results, probiotics for psoriasis actually show a genuinely encouraging and increasingly consistent pattern across multiple independent meta-analyses. Here's the real evidence.
What Multiple Meta-Analyses Have Found
Several independent systematic reviews and meta-analyses, published across different years and research groups, have now looked at probiotic supplementation for psoriasis:
- A 2024 meta-analysis of 7 randomized controlled trials found probiotics significantly reduced PASI scores compared to placebo (mean difference −3.09) and significantly reduced CRP, a key inflammatory marker (mean difference −2.36). The proportion of patients achieving PASI-75 was higher in the probiotic group (33.57% vs. 23.61%), though this specific comparison fell just short of standard statistical significance (p = 0.06).
- A separate 2024 meta-analysis (Journal of Cosmetic Dermatology) found a statistically significant reduction in PASI scores with probiotic supplementation compared to placebo.
- A 2025 meta-analysis focused specifically on gut-skin axis interventions found an even larger significant PASI improvement (mean difference −4.05) along with significant DLQI (quality of life) improvement.
This pattern — multiple independent meta-analyses converging on a significant PASI benefit — is genuinely more consistent than what we found reviewing omega-3 supplements or oral vitamin D, where different meta-analyses reached genuinely conflicting conclusions.
An Important Caveat
It's worth noting that not every individual trial included in these meta-analyses found benefit — one trial using Lactobacillus rhamnosus over 6 months found no significant PASI or DLQI difference from placebo, while others (like a multi-strain probiotic study by Moludi et al.) found more substantial improvement alongside reduced inflammatory markers. This variation suggests that strain, dose, and duration likely matter — not all probiotics are interchangeable, and the meta-analysis results represent an average across meaningfully different interventions.
The Biological Rationale
This connects directly to the gut dysbiosis research covered in our full gut microbiome article — probiotics are a logical intervention to test given the well-documented gut bacterial alterations seen in psoriasis patients. Animal studies have found specific probiotic strains can reduce psoriasiform inflammation by promoting regulatory T-cell activity and limiting excessive skin cell turnover, offering a plausible mechanism behind the clinical trial results.
What This Means Practically
- Probiotics have more consistent supportive evidence than several other commonly recommended supplements — a genuinely notable finding worth taking seriously
- This is still positioned as adjuvant (add-on) treatment in the research, not a replacement for standard prescribed treatment
- Strain matters — the studies showing the strongest benefit generally used multi-strain formulations rather than a single probiotic species, though head-to-head comparisons between specific products remain limited
- Effects on quality of life (DLQI) are less consistent than the PASI findings across studies, so expectations should be calibrated to symptom severity improvement specifically
Frequently Asked Questions
Should I add a probiotic to my psoriasis routine?
Given the increasingly consistent positive evidence, this is a reasonable, low-risk addition to discuss with your doctor — probiotics generally have a good safety profile, and the research support here is genuinely stronger than for several other commonly recommended supplements.
Which probiotic strain should I look for?
The strongest evidence comes from multi-strain formulations rather than single-strain products, though this remains an active area of research without a single definitively "best" formulation yet identified.
Next Steps
For the broader gut-skin connection, see our full gut microbiome article.
This article is for general educational purposes and is not a substitute for professional medical advice, diagnosis, or treatment.
Sources & References
- The efficacy and safety of probiotics in the adjuvant treatment of psoriasis: a systematic review and meta-analysis of randomized controlled trials. PMC11426359
- Efficacy of probiotic supplementation in the treatment of psoriasis—A systematic review and meta-analysis. Journal of Cosmetic Dermatology, 2024. Wiley
- The gut-skin axis in psoriasis: Evidence-based insights from a meta-analysis on probiotics-synbiotics-mediated microbiota interventions. ScienceDirect